Venture capital pitch event InvestMidwest seeks high-growth applicants
October 10, 2017 | Meghan LeVota
High-growth companies interested in pitching their firm to hundreds of investors can now apply to present their business at the InvestMidwest Venture Capital Forum.
The 19th annual forum will be held in St. Louis on March 28 and 29, 2018.
The event is expected to draw more than 300 investors and entrepreneurs across the Midwest, organizers say. The event has helped spur over $1 billion in early-stage investments for presenting companies over the last 17 years, said Christine Walsh InvestMidwest Executive Director.
“Companies that apply should be fast-growth companies seeking substantial investment,” Walsh said in a release. “These applications should be from entrepreneurs of fast-track companies in need of at least $1 million to push those companies forward in a dynamic drive to the next level.”
For prospective firms, the early application period concludes Nov. 10. The final deadline is set for Jan. 12, 2018.
There is no penalty for missing the early application period, but early applicants can expect benefits, Walsh said.
“It has become apparent over the years that an early application has the opportunity to receive deeper consideration,” she said. “If the selection committee members have questions, early applicants have time to clarify and strengthen their cases. That can make the difference in the committee’s decision regarding a company being invited to present at InvestMidwest.”
Up to 45 emerging businesses will be selected to pitch their company at the conference for eight minutes each. This year, the forum will include three separate industry tracks: life sciences, information technology and agriculture/bioenergy.
“We are fortunate that we regularly attract some of the Midwest region’s best, fast-growth companies and a great group of investors,” Walsh said. “The venture capital community and investors have been very satisfied with the quality of the companies they see at InvestMidwest. Consequently, we have enjoyed pretty consistent attendance every year.”
InvestMidwest was held in Kansas City in 2016, with such speakers as KCRise Fund managing director Darcy Howe, EyeVerify CEO Toby Rush, Ewing Marion Kauffman Foundation entrepreneurial advocate Nathan Kurtz, JE Dunn Construction CEO Terry Dunn and TechAccel CEO Michael Helmstetter.
The forum alternates between Kansas City and St. Louis each year. To read more about the forum and its history or to apply, click here.

2017 Startups to Watch
stats here
Related Posts on Startland News
Three tips to landing in the Techstars KC accelerator
Techstars new local accelerator is on the lookout for ten tech companies to join the Kansas City accelerator’s inaugural class. In an effort to cull suitable applicants, Techstars KC managing director Lesa Mitchell recently shared some of the top traits the program is looking for in companies. “The Techstars team in Kansas City is…
Photo gallery: Pipeline pitches and the Innovators gala
Pipeline Entrepreneurs celebrated 10 years in style Thursday at the Midland Theater. Check out this photo gallery of the organization’s pitch contest and gala. For more: Here’s a feature story on the gala. Here’s a news story on the award winners. Here’s more background on the organization and its leader, Joni Cobb.
Glitter and gratitude: Pipeline celebrates a decade of family in style
Glitz and glam; bold and gold; audacious and, more than ever, gracious. Each January, powerhouse businesspeople from around the Midwest venture to Kansas City to see if Pipeline Entrepreneurs can once again top its enchanting evening of entrepreneurial energy, now known as the Innovators. Hosted at the Midland Theater, the gala is a veritable smorgasbord…
Pipeline recognizes the Innovator of The Year, announces 2017 class
St. Louis entrepreneur Michelle Faits was dubbed Pipeline Entrepreneurs’ Innovator of the Year at last night’s culminating event, The Innovators. Faits is the founder of Pro-Arc Diagnostics — a medical startup that is developing a next-generation laboratory test for patients at risk of Progressive Multifocal Leukoencephalopathy (PML) which is caused by the John Cunningham Virus.…
